Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04072952 |
|---|---|
| Brief Title: | A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (mBC) |
| First Submitted : | August 27, 2019 |
| First Submitted that Met QC Criteria : | August 27, 2019 |
| First Posted : | August 28, 2019 |
| Last Update Submitted that Met QC Criteria : | May 3, 2024 |
| Last Update Posted : | May 6, 2024 |